AlloMap® Videos and Webcasts
AlloMap is a non-invasive genomic test that helps reassure clinicians of the absence of acute cellular rejection in heart transplant patients*.
Click on the video to watch Darren Tayama, M.D., explain the clinical fundamentals of using AlloMap testing in clinical practice.
The topics in this
1. Introduction to AlloMap
*Absence is defined here as the very low probability of moderate/severe acute cellular rejection as measured by the negative predictive value. AlloMap test results are only to be used in conjunction with standard clinical assessment.
XDx sponsors web and teleconference broadcasts on clinical topics related to the clinical utility of AlloMap testing. The goal of these programs is to have medical experts in the care of heart transplant recipients discuss topics of current interest with health care providers.
XDx Webcast ISHLT 2010 Care Guidelines:
Recommendations for the Non-Invasive Monitoring of
Acute Heart Transplant Rejection
Speaker: Jeffrey Teuteberg, MD
- Goals and Methods of ISHLT Guidelines
- Topic of Surveillance Rejection
- Major Clinical Trials (IMAGE) and Use of AlloMap Testing
Webex video link: View here.
About the Speaker:
Jeffrey Teuteberg, MD, is currently the Associate Director of Cardiac Transplantation, an Assistant Professor of Medicine, and a member of the Heart Failure/Transplant faculty in the Cardiovascular Institute at the University of Pittsburgh. Dr. Teuteberg has published numerous peer-reviewed articles, abstracts and book chapters on the subject of transplantation and mechanical circulatory support. He is also on the editorial board of the Journal of Cardiac Failure, and a contributing reviewer and writer for national medical societies and journals. Dr. Teuteberg completed his medical training and general cardiology fellowship at the University of Chicago and his Heart Failure/Transplant fellowship at Brigham and Women’s Hospital. He has been on faculty at the University of Pittsburgh since 2004.